Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation

Circulation Journal

Volumn 76, Issue 12, 2012, Pages 2748-2754

  Nakanishi, Koki ^a   Fukuda, Shota ^b   Tanaka, Atsushi ^d   Otsuka, Kenichiro ^a   Sakamoto, Makoto ^b   Taguchi, Haruyuki ^b   Yoshikawa, Junichi ^c   Shimada, Kenei ^a   Yoshiyama, Minoru ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Ekisaikai Hospital   (Japan)

^c Social Insurance Kinan Hospital   (Japan)

^d Nishinomiya Watanabe Cardiovascular Center   (Japan)

Author keywords

Atrial fibrillation; Multidetector computed tomography (MDCT); Prognosis

Indexed keywords

IOHEXOL;

ADIPOSE TISSUE; AGED; ARTICLE; BODY FAT DISTRIBUTION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; EPICARDIUM; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADIPOSE TISSUE; AGED; ATRIAL FIBRILLATION; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; KAPLAN-MEIER ESTIMATE; LINEAR MODELS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; ODDS RATIO; PERICARDIUM; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84870503159     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0637     Document Type: Article

References (42)

1. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fbrillation on the risk of death: The Fram-ingham Heart Study. Circulation 1998; 98: 946-952.
2. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fbrillation in a population-based cohort: The Framingham Heart Study. JAMA 1994; 271: 840-844.
3. Wang TJ, Parise H, Levy D, D'Agostino RB Sr, Wolf PA, Vasan RS, et al. Obesity and the risk of new-onset atrial fbrillation. JAMA 2004; 292: 2471-2477.
4. Rosengren A, Hauptman PJ, Lappas G, Olsson L, Wilhelmsen L, Swedberg K. Big men and atrial fbrillation: Effects of body size and weight gain on risk of atrial fbrillation in men. Eur Heart J 2009; 30: 1113-1120.
5. Hirata Y, Tabata M, Kurobe H, Motoki T, Akaike M, Nishio C, et al. Coronary atherosclerosis is associated with macrophage polarization in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248-255.
6. Konishi M, Sugiyama S, Sugamura K, Nozaki T, Ohba K, Matsubara J, et al. Association of pericardial fat accumulation rather than abdominal obesity with coronary atherosclerotic plaque formation in patients with suspected coronary artery disease. Atherosclerosis 2010; 209: 573-578.
7. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, et al. Human epicardial adipose tissue is a source of infammatory mediators. Circulation 2003; 108: 2460-2466.
8. Sacks HS, Fain JN. Human epicardial adipose tissue: A review. Am Heart J 2007; 153: 907-917.
9. Mahabadi AA, Massaro JM, Rosito GA, Levy D, Murabito JM, Wolf PA, et al. Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: The Framingham Heart Study. Eur Heart J 2009; 30: 850-856.
10. Lim S, Despres JP, Koh KK. Prevention of atherosclerosis in overweight/obese patients: In need of novel multi-targeted approaches. Circ J 2011; 75: 1019-1027.
11. Al Chekakie MO, Welles CC, Metoyer R, Ibrahim A, Shapira AR, Cytron J, et al. Pericardial fat is independently associated with human atrial fbrillation. J Am Coll Cardiol 2010; 56: 784-788.
12. Tsao HM, Hu WC, Wu MH, Tai CT, Lin YJ, Chang SL, et al. Quantitative analysis of quantity and distribution of epicardial adipose tissue surrounding the left atrium in patients with atrial fbrillation and effect of recurrence after ablation. Am J Cardiol 2011; 107: 1498-1503.
13. Wong CX, Abed HS, Molaee P, Nelson AJ, Brooks AG, Sharma G, et al. Pericardial fat is associated with atrial fbrillation severity and ablation outcome. J Am Coll Cardiol 2011; 57: 1745-1751.
14. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffth LS, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51: 5-40.
15. Hoffmann U, Moselewski F, Cury RC, Ferencik M, Jang IK, Diaz LJ, et al. Predictive value of 16-slice multidetector spiral computed tomography to detect signifcant obstructive coronary artery disease in patients at high risk for coronary artery disease: Patient-versus segment-based analysis. Circulation 2004; 110: 2638-2643.
16. Nakanishi K, Fukuda S, Shimada K, Ehara S, Inanami H, Matsumoto K, et al. Non-obstructive low attenuation coronary plaque predicts three-year acute coronary syndrome events in patients with hypertension: Multidetector computed tomographic study. J Cardiol 2012; 59: 167-175.
17. Gorter PM, de Vos AM, van der Graaf Y, Stella PR, Doevendans PA, Meijs MF, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102: 380-385.
18. Sarin S, Wenger C, Marwaha A, Qureshi A, Go BD, Woomert CA, et al. Clinical signifcance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008; 102: 767-771.
19. Issac TT, Dokainish H, Lakkis NM. Role of infammation in initiation and perpetuation of atrial fbrillation: A systematic review of the published data. J Am Coll Cardiol 2007; 50: 2021-2028.
20. Marcus GM, Whooley MA, Glidden DV, Pawlikowska L, Zaroff JG, Olgin JE. Interleukin-6 and atrial fbrillation in patients with coronary artery disease: Data from the Heart and Soul Study. Am Heart J 2008; 155: 303-309.
21. Mathieu P, Lemieux I, Despres JP. Obesity, infammation, and cardiovascular risk. Clin Pharmacol Ther 2010; 87: 407-416.
22. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fbrillation. Circulation 1997; 96: 1180-1184.
23. Yamashita T, Sekiguchi A, Iwasaki YK, Date T, Sagara K, Tanabe H, et al. Recruitment of immune cells across atrial endocardium in human atrial fbrillation. Circ J 2010; 74: 262-270.
24. Aviles RJ, Martin DO, Apperson-Hansen C, Houghtaling PL, Rautaharju P, Kronmal RA, et al. Infammation as a risk factor for atrial fbrillation. Circulation 2003; 108: 3006-3010.
25. Watanabe E, Arakawa T, Uchiyama T, Kodama I, Hishida H. High-sensitivity C-reactive protein is predictive of successful cardiover-sion for atrial fbrillation and maintenance of sinus rhythm after conversion. Int J Cardiol 2006; 108: 346-353.
26. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, et al. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo: The role of platelet-derived growth factor. J Clin Invest 1996; 97: 769-776.
27. Moreno PR, Purushothaman KR, Fuster V, O'Connor WN. Intimo-medial interface damage and adventitial infammation is increased beneath disrupted atherosclerosis in the aorta: Implications for plaque vulnerability. Circulation 2002; 105: 2504-2511.
28. Henrichot E, Juge-Aubry CE, Pernin A, Pache JC, Velebit V, Dayer JM, et al. Production of chemokines by perivascular adipose tissue: A role in the pathogenesis of atherosclerosis? Arterioscler Thromb Vasc Biol 2005; 25: 2594-2599.
29. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes: The third fat pad. Circulation 1997; 95: 2573-2584.
30. Iacobellis G, Leonetti F, Singh N, Sharma AM. Relationship of epi-cardial adipose tissue with atrial dimensions and diastolic function in morbidly obese subjects. Int J Cardiol 2007; 115: 272-273.
31. Mansoor A, Salciccioli L, Qureshi G, Kamran H, Rosenblum LA, Kral JG, et al. Echocardiographic determination of epicardial adipose tissue in healthy bonnet macaques. Echocardiography 2010; 27: 180-185.
32. Tsang TS, Barnes ME, Bailey KR, Leibson CL, Montgomery SC, Takemoto Y, et al. Left atrial volume: Important risk marker of incident atrial fbrillation in 1655 older men and women. Mayo Clin Proc 2001; 76: 467-475.
33. Okin PM, Wachtell K, Devereux RB, Harris KE, Jern S, Kjeldsen SE, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fbrillation in patients with hypertension. JAMA 2006; 296: 1242-1248.
34. De Vos CB, Weijs B, Crijns HJ, Cheriex EC, Palmans A, Habets J, et al. Atrial tissue Doppler imaging for prediction of new-onset atrial fbrillation. Heart 2009; 95: 835-840.
35. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantifcation: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantifcation Writing Group, developed in conjunction with the European Association of Echocar-diography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
36. Lin FY, Devereux RB, Roman MJ, Meng J, Jow VM, Jacobs A, et al. Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: Mean values among healthy adults free of hypertension and obesity. JACC Cardiovasc Imaging 2008; 1: 782-786.
37. Pritchett AM, Jacobsen SJ, Mahoney DW, Rodeheffer RJ, Bailey KR, Redfeld MM. Left atrial volume as an index of left atrial size: A population-based study. J Am Coll Cardiol 2003; 41: 1036-1043.
38. Shmilovich H, Dey D, Cheng VY, Rajani R, Nakazato R, Otaki Y, et al. Threshold for the upper normal limit of indexed epicardial fat volume: Derivation in a healthy population and validation in an outcome-based study. Am J Cardiol 2011; 108: 1680-1685.
39. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, et al. Angiotensin II receptor blockade reduces new-onset atrial fbril-lation and subsequent stroke compared to atenolol: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol 2005; 45: 712-719.
40. Healey JS, Baranchuk A, Crystal E, Morillo CA, Garfnkle M, Yusuf S, et al. Prevention of atrial fbrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A meta-analy-sis. J Am Coll Cardiol 2005; 45: 1832-1839.
41. Motoyama S, Kondo T, Anno H, Sugiura A, Ito Y, Mori K, et al. Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J 2007; 71: 363-366.
42. Pracon R, Kruk M, Kepka C, Pregowski J, Opolski MP, Dzielinska Z, et al. Epicardial adipose tissue radiodensity is independently related to coronary atherosclerosis: A multidetector computed tomography study. Circ J 2011; 75: 391-397.